Xcout Intel
JenaValve Technology Inc competitors & alternatives
The 12 closest competitors and alternatives to JenaValve Technology Inc among medical devices companies — ranked by similarity to what JenaValve Technology Inc actually does, not by market-cap band.
Subscribe to see JenaValve Technology Inc’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About JenaValve Technology Inc
JenaValve Technology, Inc. is a medical equipment manufacturing company headquartered in Irvine, California. The company specializes in developing advanced heart valves and medical solutions designed to treat conditions such as aortic regurgitation.
JenaValve Technology Inc at a glance
JenaValve Technology Inc is a medical devices company headquartered in United States. Its most recent funding round, Series C, raised $100M in August 2022. Xcout tracks 13 named people at JenaValve Technology Inc, including John Kilcoyne (Chief Executive Officer). Xcout recorded 2 job postings from JenaValve Technology Inc in the last 90 days.
JenaValve Technology Inc leadership
- John KilcoyneChief Executive Officer
- Matt BascoChief Financial Officer
- Ed SarnowskiChief Technology Officer
- Duane PintoChief Medical Officer
- Peter SpadaroChief Commercial Officer
- Connie Correa-ThomsonVP Global Human Resources
7 more named people on record for JenaValve Technology Inc, with roles, board committees and tenure — see the full roster →
JenaValve Technology Inc funding rounds
The 3 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $100M | 18 named | |
| SEC Form D filing | $35.5M | — | |
| Growth | $66.5M | 11 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at JenaValve Technology Inc
Xcout recorded 2 job postings from JenaValve Technology Inc in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see JenaValve Technology Inc's hiring signals →
Top 12 JenaValve Technology Inc competitors
Ranked by semantic similarity — how close each company is to JenaValve Technology Inc by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Medical Device
Laguna Tech USA, Inc. is a medical technology company that develops structural heart solutions, specifically focusing on transcatheter aortic valve systems. The company's flagship product, the ZETA Transcatheter Aortic Valve System, is an investigational device designed to treat both aortic regurgitation and aortic stenosis.
Similar medical devices company
Jenscare Scientific Co., Ltd. operates as a medical technology enterprise dedicated to advancing interventional therapies for structural heart conditions within the People's Republic of China. Among its pipeline, the company features LuX-Valve, an investigational transcatheter tricuspid valve replacement (TTVR) system designed for patients suffering from severe tricuspid regurgitation who face elevated surgical risks. Additionally, Ken-Valve represents another key product candidate, a transcatheter aortic valve replacement (TAVR) aimed at addressing severe aortic regurgitation, often co-occurring with aortic stenosis. The applications of Jenscare's portfolio extend to a range of structural cardiac maladies, including disorders of the tricuspid, aortic, and mitral valves, as well as heart failure. Founded in 2011, the company maintains its principal place of business in Ningbo, People's Republic of China.
Similar medical devices company
HighLife Medical is a pre-commercial stage medical device company headquartered in Paris, France, with additional facilities in Irvine, California. The company develops trans-septal mitral valve replacement (TSMVR) technologies for treating structural heart disease.
Similar medical devices company
enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced bioprosthetic, tissue-engineered solutions intended to significantly elevate the existing standards of care for patients suffering from venous conditions. Their flagship product is the VenoValve, a specialized replacement venous valve developed for the management of chronic venous insufficiency. This device requires an open surgical procedure for implantation, which involves making a 5-to-6-inch incision in the patient's upper thigh to facilitate placement into the femoral vein. In addition to the VenoValve, enVVeno Medical is actively developing the enVVe system. This innovative system represents a non-surgical, transcatheter approach to venous valve replacement, comprising the enVVe valve itself, a dedicated delivery mechanism, and various supplementary accessories. The company previously operated under the name Hancock Jaffe Laboratories, Inc., before officially rebranding to enVVeno Medical Corporation in October 2021.
Similar medical devices company
Micro Interventional Devices, Inc. is a medical equipment manufacturing company developing novel solutions for structural heart disease treatments like mitral valve repair.
Similar medical devices company
Innova Vascular, Inc. is a medical device company based in Irvine, California, engaged in the development of innovative minimally invasive vascular technologies such as the Laguna Thrombectomy System.
Similar medical devices company
BiVACOR, Inc. is a clinical-stage medical device company founded in 2008 that pioneers the development of a total artificial heart to replace failing hearts and restore patient lives. The company is headquartered in Huntington Beach, California, with clinical offices in Houston, Texas, and international facilities in Australia.
Similar medical devices company
Trisol Medical is a medical equipment manufacturing company headquartered in Yokneam, Israel. The company specializes in the design and development of medical device concepts aimed at addressing unmet clinical needs in treating Tricuspid Valve insufficiency.
Similar medical devices company
Venus Medtech (Hangzhou) Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of bioprosthetic heart valves in Mainland China and internationally. The company’s offers transcatheter aortic heart valve replacement products, such as VenusA-Valve, VenusA-Plus, VenusA-Pro, and VenusA-Deluxe; and VenusP-Valve, a transcatheter pulmonary valve system to treat the patients suffering with moderate to severe pulmonary regurgitation with or without right ventricular outflow tract stenosis. It also develops Venus-Vitae, a balloon-expandable dry-tissue product; Venus-PowerX, a self-expanding dry-tissue product; Cardiovalve, a transcatheter valve replacement system for the treatment of patients with mitral regurgitation and in pivotal clinical trial for the treatment of patients with tricuspid regurgitation; Liwen RF, a radiofrequency ablation system for the treatment of hypertrophic cardiomyopathy; and renal artery denervation ablation system for the treatment of hypertension. In addition, the company offers procedural accessories comprising catheter sheath product and balloon catheter. Venus Medtech (Hangzhou) Inc. was incorporated in 2009 and is headquartered in Hangzhou, the People’s Republic of China.
Medical Devices & Healthcare
Terumo Aortic is a global medical device company that develops and provides innovative solutions, including stent-grafts, grafts, and custom devices, for patients with aortic and peripheral vascular disease. The company serves healthcare professionals and patients by offering specialized cardiovascular and vascular management products.
Similar medical devices company
Foldax, Inc. is an award-winning medical device company headquartered in Salt Lake City, Utah. The company specializes in the development and manufacturing of innovative Tria heart valves.
Similar medical devices company
Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve. Beyond this, Anteris develops ADAPT anti-calcification tissue, a unique preparation that transforms xenograft tissue into robust bioscaffolds. These bioscaffolds are designed to simulate human tissue for various surgical repairs, notably in aortic valve replacement. Additionally, the ComASUR delivery system, a physician-designed balloon-expandable apparatus, features a reinforced, steerable catheter. This allows for highly accurate navigation through cardiac anatomy in a controlled manner, thereby mitigating potential damage to the aorta. Founded in 1999, Anteris Technologies Global Corp. operates out of Toowong, Australia.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of JenaValve Technology Inc and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for JenaValve Technology Incand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →